{"id":"W3100629716","doi":"10.1200/jco.20.02672","title":"Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":614,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenvatinib; Sorafenib; Atezolizumab; Nivolumab; Regorafenib; Ramucirumab; Oncology; Bevacizumab; Internal medicine; Pembrolizumab; Hepatocellular carcinoma; Population; Cabozantinib; Cancer; Colorectal cancer; Chemotherapy; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01072096,0.001794063,0.003064162,0.004130773,0.001229981,0.003018755,0.006198815,0.007553065,0.006088172],"category_scores_gemma":[0.02255164,0.0009095676,0.004096168,0.004450794,0.001225,0.002340931,0.00285332,0.008125608,0.007149335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005816407,"about_ca_system_score_gemma":0.02356834,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02115037,"about_ca_topic_score_gemma":0.02651194,"domain_scores_codex":[0.9892617,0.00394944,0.00331167,0.000479437,0.002514471,0.0004831921],"domain_scores_gemma":[0.9803708,0.003489392,0.003384082,0.0005213245,0.01062604,0.001608502],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007149646,0.0001108404,0.0009026608,0.009603721,0.00023583,0.0002690186,0.0001549054,0.001132932,0.0004104759,0.003699854,0.8393037,0.1441046],"study_design_scores_gemma":[0.0004193966,0.0001206043,0.002812781,0.05637416,0.000646645,0.0007301081,0.0001431425,0.0009666182,0.0003670216,0.006360196,0.9309829,0.00007626192],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"methods","genre_scores_codex":[0.002919458,0.3282182,0.03085261,0.4589448,0.02220753,0.01132822,0.02311666,0.00142244,0.1209902],"genre_scores_gemma":[0.02170268,0.3726757,0.1854429,0.2918765,0.01335761,0.01422347,0.05993531,0.0006151815,0.04017063],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.02115037,"threshold_uncertainty_score":0.0566985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2489958274625802,"score_gpt":0.5172099093082254,"score_spread":0.2682140818456452,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}